{"id":6800,"date":"2013-05-24T06:41:31","date_gmt":"2013-05-24T10:41:31","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=6800"},"modified":"2013-05-24T06:41:31","modified_gmt":"2013-05-24T10:41:31","slug":"ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800","title":{"rendered":"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/24\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Ziopharm Oncology Inc. (NASDAQ:ZIOP) surged to an intraday high price of $2.02 per share before closing at 18.13 percent higher than the previous day\u2019s closing price. The intraday low price of the share was observed to be $1.71 per share. Ziopharm Oncology Inc. (NASDAQ:ZIOP) has a 52 week low price level of $1.49 per share and 52 week high price level of $6.33 per share.<\/p>\n<p style=\"text-align: justify;\">The gradual increase in the share prices of Ziopharm Oncology Inc. (NASDAQ:ZIOP) had led the company to enter into NASDAQ gainers watch list. The company also witnessed heavy trading in its shares where nearly 2.55 million shares exchanged hands during the day while the average trading volume of the company is only 885,669 shares per day. Ziopharm Oncology Inc. (NASDAQ:ZIOP) is a bio pharmaceutical company with major focus on new cancer therapies.<\/p>\n<p style=\"text-align: justify;\">The company is in the research and development of new treatment therapies for cancer patients through application of therapeutics. The product lines of Ziopharm Oncology Inc. (NASDAQ:ZIOP) presently consists of five clinical stage candidates and multiple research stage candidates. \u00a0ZIOPHARM\u2019s clinical programs include palifosfamide (ZIO-201), IL-12 DNA, indibulin (ZIO-301) and darinaparsin (ZIO-101).<\/p>\n<p style=\"text-align: justify;\">The shares of the company had recently witnessed gradual increase in their prices owing to the consistent performance of Ziopharm Oncology Inc. (NASDAQ:ZIOP). The bio pharmaceutical company presently has 83.56 million shares outstanding in the market and the institutional ownership in Ziopharm Oncology Inc. (NASDAQ:ZIOP) is 52 percent of its holdings. The market capitalization for the company is presently $168.80 million.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/24\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Ziopharm Oncology Inc. (NASDAQ:ZIOP) surged to an intraday high price of $2.02 per share before closing at [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":6801,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2269,2268],"stock_ticker":[],"class_list":["post-6800","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqziop","tag-ziopharm-oncology-inc-nasdaqziop","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/24\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Ziopharm Oncology Inc. (NASDAQ:ZIOP) surged to an intraday high price of $2.02 per share before closing at [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-24T10:41:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list\",\"datePublished\":\"2013-05-24T10:41:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800\"},\"wordCount\":266,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg\",\"keywords\":[\"NASDAQ:ZIOP\",\"Ziopharm Oncology Inc. (NASDAQ:ZIOP)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800\",\"name\":\"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg\",\"datePublished\":\"2013-05-24T10:41:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800","og_locale":"en_US","og_type":"article","og_title":"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list - Wall Street PR","og_description":"Boston, MA 05\/24\/2013 (wallstreetpr) &#8211;\u00a0The share prices of Ziopharm Oncology Inc. (NASDAQ:ZIOP) surged to an intraday high price of $2.02 per share before closing at [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-05-24T10:41:31+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list","datePublished":"2013-05-24T10:41:31+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800"},"wordCount":266,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg","keywords":["NASDAQ:ZIOP","Ziopharm Oncology Inc. (NASDAQ:ZIOP)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800","url":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800","name":"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg","datePublished":"2013-05-24T10:41:31+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/soldi.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-is-in-nasdaq-gainers-watch-list-6800#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Ziopharm Oncology Inc. (NASDAQ:ZIOP) is in NASDAQ gainers watch list"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/6800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=6800"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/6800\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/6801"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=6800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=6800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=6800"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=6800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}